A New Look at Behavioral Outcomes and Teratogens: A Commentary

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 11, 2003, Pages 900-902

  Cordero, José F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALCOHOL; FOLIC ACID; HOMOCYSTEINE; ISOTRETINOIN; MEASLES MUMPS RUBELLA VACCINE; MERCURY; NEW DRUG; TERATOGENIC AGENT; THALIDOMIDE; VALPROIC ACID;

ALCOHOL ABUSE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR; BIRTH DEFECT; CASE CONTROL STUDY; CEREAL; COGNITIVE DEVELOPMENT; DEVELOPMENTAL DISORDER; DIGITALIZATION; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; FETAL ALCOHOL SYNDROME; FEVER; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INTRAUTERINE INFECTION; LEARNING DISORDER; LONGITUDINAL STUDY; MATERNAL DISEASE; NERVE CELL DIFFERENTIATION; NOTE; PHOCOMELIA; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; RUBELLA; SPINA BIFIDA; TEMPERAMENT; TERATOGENICITY; TERATOLOGY; UNITED STATES;

ABNORMALITIES, DRUG-INDUCED; BEHAVIOR; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RESEARCH DESIGN; TERATOGENS;

EID: 0344012588     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10125     Document Type: Note

References (15)

1. Andrews EB, Yankaskas BC, Cordero JF, et al. 1992. Acyclovir in pregnancy registry: six years' experience. The Acyclovir in Pregnancy Registry Advisory Committee. Obstet Gynecol 79:7-13.
2. The National Children's Study. 2003. http://nationalchildrensstudy.gov/ (updated 2003; accessed August 3, 2003).
3. Chen RT, Glasser J, Rhodes P, et al. 1997. The vaccine safety datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics 99:765-773.
4. Dombrowski, SC, Marting RP, Huttunen, MO. 2003. Association between maternal rever and psychological/behavior outcomes: a hypothesis. Birth Defects Res Part A Clin Mol Teratol 67:000-000.
5. Gregg NM. 1941. Congenital cataracts following German measles in the mother. Trans Ophthalmol Soc Aust 3:35-46.
6. Heinonen OP, Slone D, Shapiro S. 1977. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group.
7. Jones KL, Smith DW, Ulleland CN, Streissguth P. 1973. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 9:1267-1271.
8. Lammer EJ, Chen DT, Hoar RM, et al. 1985. Retinoic acid embryopathy. N Engl J Med 313:837-841.
9. Madsen KM, Hviid A, Vestergaard M, et al. 2002. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347:1477-1482.
10. Myrianthopoulos NC, Chung CS. 1974. Congenital malformations in singletons: epidemiologic survey. Report from the collaborative perinatal project. Birth Defects Orig Artic Ser 10:1-58.
11. National Institutes of Health. 2002. National Heart, Lung, and Blood Institute and Boston University. Framingham heart study. 50 years of success. http://www.nhlbi.nih.gov/about/framingham/biblio.html (updated December 2002; accessed August 8, 2003)
12. Rader JI. 2002. Folic acid fortification, folate status and plasma homocysteine. J Nutr 132(Suppl 8):2466S-2470S.
13. Robert E, Lofkvist E, Mauguiere F. 1984. Valproate and spina bifida. Lancet 2:1392.
14. Warkany J. 1971. Thalidomide. In: Warkany J, editor. Congenital malformations: notes and comments. Chicago: Yearbook Medical Publishers. pp. 84-86.
15. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The national birth defects prevention study. Public Health Rep 116.